(Q38123553)

29 August 2017

Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis (English)

1 reference

29 August 2017

0 references

1 reference

J Russell Stothard

1

1 reference

PubMed ID

23879611

29 August 2017

José C Sousa-Figueiredo

series ordinal

2

1 reference

PubMed ID

23879611

29 August 2017

Annalan M D Navaratnam

series ordinal

3

1 reference

29 August 2017

1 July 2013

1 reference

Expert Review of Anti-infective Therapy

29 August 2017

1 reference

29 August 2017

11

1 reference

29 August 2017

7

1 reference

29 August 2017

733-752

1 reference

Parasites and poverty: the case of schistosomiasis

29 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

The immunobiology of schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Schistosomiasis in African infants and preschool children: to treat or not to treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Rapid mapping of schistosomiasis and other neglected tropical diseases in the context of integrated control programmes in Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Schistosomiasis collection at NHM (SCAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Genetic diversity of schistosomes and snails: implications for control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Zoonotic schistosomiasis in non-human primates: past, present and future activities at the human-wildlife interface in Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Bidirectional introgressive hybridization between a cattle and human schistosome species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Rapid diagnostic multiplex PCR (RD-PCR) to discriminate Schistosoma haematobium and S. bovis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Preventive chemotherapy and the fight against neglected tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Control of neglected tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Africa is desperate for praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Schistosomiasis in Africa: an emerging tragedy in our new global health decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Rescuing the bottom billion through control of neglected tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Process evaluation of schistosomiasis control in Uganda, 2003 to 2006: perceptions, attitudes and constraints of a national programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Present and future schistosomiasis control activities with support from the Schistosomiasis Control Initiative in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Schistosomiasis and soil-transmitted helminth control in Niger: cost effectiveness of school based and community distributed mass drug administration [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Schistosomiasis control in Africa: 8 years after World Health Assembly Resolution 54.19

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

New initiatives against Africa's worms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Recent progress in integrated neglected tropical disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Will increased funding for neglected tropical diseases really make poverty history?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

The control of schistosomiasis and soil-transmitted helminths in East Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Neglected tropical diseases in Uganda: the prospect and challenge of integrated control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Schistosomiasis and soil-transmitted helminthiasis control in Cameroon and Côte d'Ivoire: implementing control on a limited budget

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

How to (or not to) integrate vertical programmes for the control of major neglected tropical diseases in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Integrated prevalence mapping of schistosomiasis, soil-transmitted helminthiasis and malaria in lakeside and island communities in Lake Victoria, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Epidemiology and control of intestinal schistosomiasis on the Sesse Islands, Uganda: integrating malacology and parasitology to tailor local treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Confirmed local endemicity and putative high transmission of Schistosoma mansoni in the Sesse Islands, Lake Victoria, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Towards defining appropriate strategies for targeted NTD control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Planning schistosomiasis control: investigation of alternative sampling strategies for Schistosoma mansoni to target mass drug administration of praziquantel in East Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Optimal survey designs for targeting chemotherapy against soil-transmitted helminths: effect of spatial heterogeneity and cost-efficiency of sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

A comparative study of the spatial distribution of schistosomiasis in Mali in 1984-1989 and 2004-2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Bayesian spatial analysis of a national urinary schistosomiasis questionnaire to assist geographic targeting of schistosomiasis control in Tanzania, East Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Spatial co-distribution of neglected tropical diseases in the east African great lakes region: revisiting the justification for integrated control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Mapping the probability of schistosomiasis and associated uncertainty, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Control of schistosomiasis in sub-Saharan Africa: progress made, new opportunities and remaining challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Treatment of schistosomiasis in African infants and preschool-aged children: downward extension and biometric optimization of the current praziquantel dose pole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

An inclusive dose pole for treatment of schistosomiasis in infants and preschool children with praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Paradigm lost: how parasite control may alter pattern and process in human helminthiases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Evaluating the epidemiological impact of national control programmes for helminths

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Morbidity due to Schistosoma mansoni: an epidemiological assessment of distended abdomen syndrome in Ugandan school children with observations before and 1-year after anthelminthic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Measuring fitness of Kenyan children with polyparasitic infections using the 20-meter shuttle run test as a morbidity metric

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Measuring morbidity associated with urinary schistosomiasis: assessing levels of excreted urine albumin and urinary tract pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Urinary schistosomiasis-associated morbidity in schoolchildren detected with urine albumin-to-creatinine ratio (UACR) reagent strips

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

HIV/AIDS, schistosomiasis, and girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

A review of female genital schistosomiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Female genital schistosomiasis - icebergs of morbidity ahead?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Schistosomiasis in African infants and preschool children: let them now be treated!

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

A schistosomiasis research agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Drugs for the control of parasitic diseases: current status and development in schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Will new antischistosomal drugs finally emerge?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Decades down the line: the viability of praziquantel for future schistosomiasis treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

The immune dependence of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Counterfeit praziquantel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Changes in specific anti-egg antibody levels following treatment with praziquantel for Schistosoma haematobium infection in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, Southern Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Praziquantel efficacy against schistosomiasis mansoni in schoolchildren in north-west Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Urinary soluble egg antigen levels in Schistosoma haematobium infection in relation to sex and age of Kenyan schoolchildren following praziquantel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

The relationship between prevalence of Schistosoma haematobium infection and different morbidity indicators during the course of a control programme on Pemba Island

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Praziquantel: a new schistosomicide against Schistosoma haematobium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

The effect of single dose versus two doses of praziquantel on Schistosoma haematobium infection and pathology among school-aged children in Mali

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Sequential analysis of helminth egg output in human stool samples following albendazole and praziquantel administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

Resisting control of neglected tropical diseases: dilemmas in the mass treatment of schistosomiasis and soil-transmitted helminths in north-west Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2013.811931

10.1586/14787210.2013.811931

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23879611